JP2015502991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502991A5 JP2015502991A5 JP2014539909A JP2014539909A JP2015502991A5 JP 2015502991 A5 JP2015502991 A5 JP 2015502991A5 JP 2014539909 A JP2014539909 A JP 2014539909A JP 2014539909 A JP2014539909 A JP 2014539909A JP 2015502991 A5 JP2015502991 A5 JP 2015502991A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composite hydrogel
- hydrogel according
- bioactive agent
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 claims 33
- 239000002131 composite material Substances 0.000 claims 32
- 229920000642 polymer Polymers 0.000 claims 17
- 239000012867 bioactive agent Substances 0.000 claims 12
- 235000001014 amino acid Nutrition 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- -1 aliphatic amino acid Chemical class 0.000 claims 4
- 150000003862 amino acid derivatives Chemical class 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 125000006239 protecting group Chemical group 0.000 claims 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 3
- 230000007935 neutral effect Effects 0.000 claims 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 229920006318 anionic polymer Polymers 0.000 claims 2
- 210000004899 c-terminal region Anatomy 0.000 claims 2
- 229920006317 cationic polymer Polymers 0.000 claims 2
- 102000008395 cell adhesion mediator activity proteins Human genes 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 238000012377 drug delivery Methods 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 239000007943 implant Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- BEWCSNDRHAIGAY-BYPYZUCNSA-N (2s)-2-amino-4-methyltellanylbutanoic acid Chemical compound C[Te]CC[C@H](N)C(O)=O BEWCSNDRHAIGAY-BYPYZUCNSA-N 0.000 claims 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 1
- NPSWHDAHNWWMEG-UHFFFAOYSA-N 2-aminohex-5-enoic acid Chemical compound OC(=O)C(N)CCC=C NPSWHDAHNWWMEG-UHFFFAOYSA-N 0.000 claims 1
- SCGJGNWMYSYORS-UHFFFAOYSA-N 2-azaniumylhex-5-ynoate Chemical compound OC(=O)C(N)CCC#C SCGJGNWMYSYORS-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims 1
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 claims 1
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 claims 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- NUXSIDPKKIEIMI-LURJTMIESA-N N(6)-carboxymethyl-L-lysine Chemical compound OC(=O)[C@@H](N)CCCCNCC(O)=O NUXSIDPKKIEIMI-LURJTMIESA-N 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 229960002173 citrulline Drugs 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- BKGWACHYAMTLAF-BYPYZUCNSA-N l-thiocitrulline Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)S BKGWACHYAMTLAF-BYPYZUCNSA-N 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 229960002718 selenomethionine Drugs 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 229940026510 theanine Drugs 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG201108178-3 | 2011-11-04 | ||
| SG2011081783 | 2011-11-04 | ||
| PCT/SG2012/000421 WO2013066274A1 (en) | 2011-11-04 | 2012-11-05 | Self-assembled composite ultrasmall peptide-polymer hydrogels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015502991A JP2015502991A (ja) | 2015-01-29 |
| JP2015502991A5 true JP2015502991A5 (enExample) | 2015-12-24 |
| JP6143269B2 JP6143269B2 (ja) | 2017-06-07 |
Family
ID=54256948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539909A Expired - Fee Related JP6143269B2 (ja) | 2011-11-04 | 2012-11-05 | 自己組織化複合超小型ペプチドポリマーヒドロゲル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10449257B2 (enExample) |
| EP (1) | EP2773696B1 (enExample) |
| JP (1) | JP6143269B2 (enExample) |
| SG (1) | SG11201401964TA (enExample) |
| WO (1) | WO2013066274A1 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9067084B2 (en) | 2010-03-31 | 2015-06-30 | Agency For Science, Technology And Research | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| US8999916B2 (en) | 2010-03-31 | 2015-04-07 | Agency For Science, Technology And Research | Crosslinked peptide hydrogels |
| US9687591B2 (en) * | 2010-03-31 | 2017-06-27 | Agency For Science, Technology And Research | Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP3431485B2 (en) | 2010-10-01 | 2024-09-04 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| WO2012135805A2 (en) | 2011-03-31 | 2012-10-04 | modeRNA Therapeutics | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2763701B1 (en) | 2011-10-03 | 2018-12-19 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| SG11201401964TA (en) | 2011-11-04 | 2014-05-29 | Agency Science Tech & Res | Self-assembled composite ultrasmall peptide-polymer hydrogels |
| KR20140102759A (ko) | 2011-12-16 | 2014-08-22 | 모더나 세라퓨틱스, 인코포레이티드 | 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물 |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| DE18200782T1 (de) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
| CA2892529C (en) | 2012-11-26 | 2023-04-25 | Moderna Therapeutics, Inc. | Terminally modified rna |
| SG2012096699A (en) | 2012-12-31 | 2014-07-30 | Agency Science Tech & Res | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| CN105102469A (zh) * | 2013-01-28 | 2015-11-25 | 新加坡科技研究局 | 交联的肽水凝胶 |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| EA201690675A1 (ru) | 2013-10-03 | 2016-08-31 | Модерна Терапьютикс, Инк. | Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности |
| CN105828838B (zh) * | 2013-10-18 | 2020-03-10 | 新加坡科技研究局 | 含有纳米粒子的水凝胶 |
| WO2015080671A1 (en) * | 2013-11-30 | 2015-06-04 | Agency For Science, Technology And Research | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing |
| EP3074415A4 (en) * | 2013-11-30 | 2017-09-20 | Agency For Science, Technology And Research | Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses |
| JP6301136B2 (ja) * | 2014-01-22 | 2018-03-28 | コンビ株式会社 | ポリアミンを有効成分とする、軟骨組織の再生を促進するための組成物 |
| EP3167277A4 (en) * | 2014-07-08 | 2018-03-07 | Agency For Science, Technology And Research | Ultrashort peptides as exogenous second harmonic probes for bioimaging applications |
| FR3038318B1 (fr) * | 2015-07-02 | 2017-08-04 | Univ De Lille 1 Sciences Et Technologies | Procede de fabrication d'hydrogel a base de chitosan et de polyelectrolytes charges negativement et materiau poreux alveolaire issu dudit hydrogel |
| KR101912826B1 (ko) * | 2016-10-25 | 2018-10-30 | 한국생산기술연구원 | 특정분자 친화력을 갖는 하이드로겔 및 이를 이용한 하이드로겔의 부피 조절 방법 |
| US20180214476A1 (en) * | 2017-02-01 | 2018-08-02 | North Carolina State University | Thrombin-responsive hydrogels and devices for auto-anticoagulant regulation |
| KR102418307B1 (ko) * | 2017-05-11 | 2022-07-06 | 킹 압둘라 유니버시티 오브 사이언스 앤드 테크놀로지 | 미세유체공학-기반 3d 바이오프린팅용 장치 및 방법 |
| WO2018207036A1 (en) | 2017-05-11 | 2018-11-15 | King Abdullah University Of Science And Technology | A peptide capable of forming a gel for use in tissue engineering and bioprinting |
| CN107043467B (zh) * | 2017-06-02 | 2020-06-19 | 东华大学 | 一种可光交联水凝胶及其制备方法 |
| US11786607B2 (en) | 2017-06-15 | 2023-10-17 | Modernatx, Inc. | RNA formulations |
| US11839661B2 (en) | 2017-08-15 | 2023-12-12 | Brandeis University | Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| CN109554331B (zh) * | 2017-09-27 | 2022-09-27 | 清华大学 | L-核酸水凝胶 |
| CN108992670B (zh) * | 2018-07-24 | 2021-06-08 | 武汉理工大学 | 一种近红外光聚合可注射水凝胶的制备与应用 |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| CN109294142B (zh) * | 2018-11-15 | 2021-03-30 | 湖北大学 | 一种水凝胶、油水分离器及其制备方法和应用 |
| CN109646711A (zh) * | 2019-01-29 | 2019-04-19 | 青岛中腾生物技术有限公司 | 一种医用止血封闭防黏连材料 |
| CN110204593A (zh) * | 2019-05-17 | 2019-09-06 | 高邮市宇航化工机械厂 | 一种生物制药用多肽化合物的制备工艺 |
| US12109327B2 (en) | 2020-08-20 | 2024-10-08 | King Abdullah University Of Science And Technology | Scaffolds from self-assembling tetrapeptides support 3D spreading, osteogenic differentiation and angiogenesis of mesenchymal stem cells |
| US11673324B2 (en) | 2020-08-20 | 2023-06-13 | King Abdullah University Of Science And Technology | Nozzle for 3D bioprinting |
| CN113121642A (zh) * | 2020-09-22 | 2021-07-16 | 中国药科大学 | 自组装多肽、氧化还原响应多肽水凝胶及其制备方法和应用 |
| CN112138208A (zh) * | 2020-09-28 | 2020-12-29 | 深圳清华大学研究院 | 促血管化组织再生的支架材料及其制备方法 |
| CN112807483B (zh) * | 2021-02-03 | 2022-10-21 | 中国药科大学 | 一种抗炎、抗菌、止血的双网络水凝胶及其制备方法和应用 |
| CN115429929B (zh) * | 2021-06-04 | 2024-08-13 | 中国科学院上海硅酸盐研究所 | 一种可注射自组装水凝胶及其制备方法和应用 |
| CN113384743A (zh) * | 2021-07-09 | 2021-09-14 | 吉林省国大生物工程有限公司 | 一种具有促进组织修复及抗菌的温敏敷料的制备方法 |
| CN116003826B (zh) * | 2021-10-22 | 2024-12-20 | 中山大学附属第三医院（中山大学肝脏病医院） | 一种可注射改性透明质酸/功能性短肽复合水凝胶及其制备方法和应用 |
| CN114381015A (zh) * | 2021-12-24 | 2022-04-22 | 中山大学附属第三医院（中山大学肝脏病医院） | 一种可注射和自修复的水凝胶及其制备方法和应用 |
| CN114904057B (zh) * | 2022-04-20 | 2023-06-09 | 华中科技大学同济医学院附属协和医院 | 一种抑制神经长入的复合纤维环凝胶制备方法及应用 |
| CN116212098B (zh) * | 2023-03-14 | 2024-08-13 | 四川大学 | 一种酸性环境快速响应型多肽粘合剂的制备方法 |
| CN120818235B (zh) * | 2025-09-19 | 2025-12-05 | 中南大学湘雅医院 | 一种高分子复合水凝胶及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009124388A1 (en) * | 2008-04-09 | 2009-10-15 | Mcmaster University | Hydrogel with covalently crosslinked core |
| US20110081398A1 (en) | 2009-10-01 | 2011-04-07 | Tyco Healthcare Group Lp | Multi-mechanism surgical compositions |
| US9067084B2 (en) | 2010-03-31 | 2015-06-30 | Agency For Science, Technology And Research | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| SG11201401964TA (en) | 2011-11-04 | 2014-05-29 | Agency Science Tech & Res | Self-assembled composite ultrasmall peptide-polymer hydrogels |
-
2012
- 2012-11-05 SG SG11201401964TA patent/SG11201401964TA/en unknown
- 2012-11-05 EP EP12846222.3A patent/EP2773696B1/en not_active Not-in-force
- 2012-11-05 JP JP2014539909A patent/JP6143269B2/ja not_active Expired - Fee Related
- 2012-11-05 WO PCT/SG2012/000421 patent/WO2013066274A1/en not_active Ceased
- 2012-11-05 US US14/356,116 patent/US10449257B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502991A5 (enExample) | ||
| Yadav et al. | Short to ultrashort peptide-based hydrogels as a platform for biomedical applications | |
| US10464968B2 (en) | Method for producing a composition for treating a tooth lesion | |
| Xu et al. | Advanced materials for enamel remineralization | |
| KR101757946B1 (ko) | 근 수축을 억제하는 화합물 | |
| CN101588820A (zh) | α-乳清蛋白组合物 | |
| KR102410065B1 (ko) | 피브리노겐-결합 펩타이드를 포함하는 펩타이드 덴드리머 | |
| EP3086818B1 (en) | One component fibrin glue comprising a polymerization inhibitor | |
| HRP20191852T1 (hr) | Polipeptidi | |
| WO2014104981A1 (en) | Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications | |
| JP2017501136A5 (enExample) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| CN102731629B (zh) | 一种抗菌肽及其应用 | |
| JP2013538864A (ja) | 生物活性アミノ酸配列及びその使用 | |
| CN103304631A (zh) | 具有抗肿瘤活性的九肽 | |
| JP2009533355A5 (enExample) | ||
| AU2021401137B2 (en) | Pharmaceutical composition of glp-1/glp-2 dual agonists | |
| US20160228569A1 (en) | Peptide constructs and well-defined aggregates thereof | |
| CA3200525A1 (en) | Pharmaceutical composition of glp-1/glp-2 dual agonists | |
| EP2717896B1 (en) | Therapeutic agents for regulating serum phosphorus | |
| RU2011133224A (ru) | Новые фармацевтические композиции | |
| CN108367094B (zh) | 肽组合物 | |
| US11661439B2 (en) | Peptide hydrogels and use thereof | |
| Quigley et al. | ẞ-Sheet and ẞ-Hairpin Peptide | |
| Cheng et al. | Preparation of Supramolecular Hydrogel Made of D-Amino Acid and Their Applications in Cancer Treatment |